3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
154
Head & Neck
4
Gastrointestinal
4
Lymphoid
3
Gynecologic
3
Genitourinary
3
Thoracic
2
Sarcoma
2
Plasma cell
1
Other solid neoplasm
1
Other neoplasm
1
Other hematologic neoplasm
1
Myeloid
1
Endocrine
1
Dermatologic
1
Classical hematology
1
CNS
1
Conditions
Anemia, Refractory, with Excess of Blasts
255
Myelodysplastic Syndromes
228
Leukemia, Myeloid, Acute
228
Anemia
212
Leukemia
205
Precursor Cell Lymphoblastic Leukemia-Lymphoma
168
Leukemia, Myelomonocytic, Chronic
145
Neoplasms
142
Leukemia, Lymphocytic, Chronic, B-Cell
116
Myeloproliferative Disorders
114
Multiple Myeloma
113
Lymphoma, Non-Hodgkin
105
Thrombocytopenia
100
Lymphoma
98
Hodgkin Disease
91
Anemia, Refractory
81
Venous Thromboembolism
77
Congenital Abnormalities
77
Anemia, Aplastic
77
Primary Myelofibrosis
76
Lymphoma, Follicular
73
Leukemia, Myeloid, Chronic-Phase
70
Blast Crisis
67
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
65
Leukemia, Myeloid, Accelerated Phase
64
Lymphoma, Mantle-Cell
63
Febrile Neutropenia
62
Myelodysplastic-Myeloproliferative Diseases
58
Hematologic Neoplasms
56
Burkitt Lymphoma
56
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Breast Carcinoma In Situ
×
Classical hematology
×
Clear all
NCT02728596
2022-10-20
TrACER
SWOG Cancer Research Network
Phase NA
Completed
3,665 enrolled
17 charts